Onset of clinical and MRI efficacy occurs early after fingolimod treatment initiation in relapsing multiple sclerosis

To minimize the clinical burden associated with multiple sclerosis (MS), early control of focal and diffuse CNS disease activity is a treatment priority. A post hoc analysis was conducted to evaluate the onset of efficacy of fingolimod treatment in patients with relapsing MS. Data from patients who...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Neurol
Egile Nagusiak: Kappos, Ludwig, Radue, Ernst-Wilhelm, Chin, Peter, Ritter, Shannon, Tomic, Davorka, Lublin, Fred
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Berlin Heidelberg 2015
Gaiak:
Original Communication
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4751181/
https://ncbi.nlm.nih.gov/pubmed/26645392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-015-7978-y
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak